WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
Health Technology Investment Act Introduced in the House
The bipartisan Health Technology Investment Act (H.R. 6197) was recently introduced in the House of Representatives by Reps. John…
Read MoreMichelle Beck Shares Patient Advocacy Journey
Michelle Beck, patient advocate and breast cancer survivor, recently sat down with Right Scan Right Time to share…
Read MoreRight Scan Right Time Joins 65 Patient Groups Urging CMS to Create a More Robust Medical Technology Breakthrough Rule
Right Scan Right Time, along with 65 other patient groups, sent a letter to Administrator Oz at the…
Read MoreHere’s How Medtech Is Making Americans Healthier
In a recent Washington Times op-ed titled, “Medtech is Vital to a Healthier America,” Scott Whitaker, president and CEO of…
Read More